File:Amphetamine_structure.svg · Wikimedia Commons · See Wikimedia Commons
DL-amphetamine
Sign in to saveAlso known as β-aminopropylbenzene, β-phenylisopropylamine, 1-phenyl-2-aminopropane, α-methylbenzeneethaneamine, α-methylphenethylamine, (±)-amphetamine, 1-phenylpropan-2-amin, alpha-methylbenzeneethaneamine
Amphetamine is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; it is also used to treat binge eating disorder in the form of lisdexamfetamine. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. It is a prescription drug in many countries, and unauthorized possession and distribution of amphetamine are often tightly controlled due to the significant
OverviewAI-generated
DL-amphetamine is a chemical compound with the formula C₉H₁₃N. Its IUPAC name is 1-phenylpropan-2-amine. The substance has a molecular mass of 135.104799 and a density of 0.936. It melts at 11.3 degrees and boils at 203 degrees. The defined daily dose is 15.
Chemical properties include a charge of 0, one hydrogen bond donor, and one hydrogen bond acceptor. The xlogp value is 1.8, and the topological polar surface area is 26. The canonical SMILES notation for the molecule is CC(CC1=CC=CC=C1)N.
Synthesized by Vinony from 22 facts across 4 sources: Wikidata, PubChem, PubMed, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Drug.Watchedfields
- correct
- Drug.synonyms
- α-methylphenethylamine, β-phenylisopropylamine, thyramine
- Drug.ChEBI
- 2679
- Drug.ChEMBL
- 405
- Drug.NIAID_ChemDB
- 018564
- Drug.C
- 9
- Drug.H
- 13
- Drug.N
- 1
- Drug.chirality
- Racemic mixture
- Drug.density
- .936
- Drug.density_notes
- at 25 °C
- Drug.SMILES
- NC(C)Cc1ccccc1
- Drug.Verifiedfields
- correct
- Drug.verifiedrevid
- 851154960r
- Drug.INN
- Amfetamine
- Drug.image
- Amphetamine structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 215px
via Wikipedia infobox
Chemical data
- Formula
- C9H13N
- Molecular weight
- 135.21 g/mol
- IUPAC name
- 1-phenylpropan-2-amine
- SMILES
- CC(CC1=CC=CC=C1)N
- InChIKey
- KWTSXDURSIMDCE-UHFFFAOYSA-N
- XLogP
- 1.8
- Polar surface area
- 26 Ų
- H-bond donors
- 1
- H-bond acceptors
- 1
- Formal charge
- 0
via PubChem
Research
34,964 papers- Amphetamine.Lancet (London, England) · 1947HOWARD CDOI: 10.1016/s0140-6736(47)91924-7
- Amphetamine-related disorders.ReviewThe Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society · 1998Czerwinski WP
- Amphetamine drugs.Public health reports (Washington, D.C. : 1896) · 1960FLEMMING AS
- [Amphetamine abuse and drug interactions].ReviewUgeskrift for laeger · 2014Horwitz H, Skanning P, Askaa B et al.
- Amphetamine in surgery.Lancet (London, England) · 1947FATTI LDOI: 10.1016/s0140-6736(47)90166-9
- A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine.The Journal of pharmacology and experimental therapeutics · 1981Johanson CE, Schuster CR
- Overdose of amphetamine.Lancet (London, England) · 1949FRANKEL EDOI: 10.1016/s0140-6736(49)91903-0
- Discriminative stimulus properties of a low dl-amphetamine dose.Archives internationales de pharmacodynamie et de therapie · 1976Colpaert FC, Kuyps JJ, Niemegeers CJ et al.
via PubMed
Wikidata facts
- Mass
- 135.104799
- Has use
- medication
Show 16 more facts
- significant drug interaction
- tranylcypromine
- Commons category
- Amphetamine
- topic's main category
- Category:Amphetamine
- World Health Organisation international non-proprietary name
- 苯丙胺
- physically interacts with
- solute carrier family 6 member 3
- chemical formula
- C₉H₁₃N
- medical condition treated
- obesity
- canonical SMILES
- CC(CC1=CC=CC=C1)N
- melting point
- 11.3
- boiling point
- 203
- density
- 0.936
- subject has role
- nootropic
- different from
- D-methamphetamine
- found in taxon
- Senegalia berlandieri
- defined daily dose
- 15
- legal status (medicine)
- boxed warning
Sources (11)
via Wikidata · CC0
~74 min read
Encyclopedic overview
44 sectionsContents
- Uses
- Medical
- ADHD
- Binge eating disorder
- Narcolepsy
- Enhancing performance
- Cognitive performance
- Physical performance
- Recreational
- Contraindications
- Adverse effects
- Physical
- Psychological
- Reinforcement disorders
- Addiction
- Biomolecular mechanisms
- Pharmacological treatments
- Behavioral treatments
- Dependence and withdrawal
- Overdose
- Toxicity
- Psychosis
- Drug interactions{{anchor|Interactions}}
- Pharmacology
- Pharmacodynamics
- Dopamine
- Norepinephrine
- Serotonin
- Other neurotransmitters, peptides, hormones, and enzymes
- Sex-dependent differences
- Pharmacokinetics
- Pharmacomicrobiomics
- Related endogenous compounds
- Chemistry
- Substituted derivatives
- Synthesis
- Detection in body fluids
- History, society, and culture
- Legal status
- Pharmaceutical products
- Notes
- Reference notes
- References
- External links
Amphetamine is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; it is also used to treat binge eating disorder in the form of lisdexamfetamine. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. It is a prescription drug in many countries, and unauthorized possession and distribution of amphetamine are often tightly controlled due to the significant health risks associated with recreational use.
Amphetamine was discovered as a chemical in 1887 by Lazăr Edeleanu, and then as a drug in the late 1920s. It exists as two enantiomers: levoamphetamine and dextroamphetamine. The first amphetamine pharmaceutical was Benzedrine. Pharmaceutical amphetamine is prescribed as racemic amphetamine, Adderall, dextroamphetamine, or lisdexamfetamine. Amphetamine increases monoamine and excitatory neurotransmission in the brain, with its most pronounced effects targeting the norepinephrine and dopamine neurotransmitter systems.
Excerpted from Wikipedia’s “DL-amphetamine” article, available under the CC BY-SA 4.0 licence.
Gallery (13)
Available in 64 languages
- Español
- Français
- Deutsch
- 中文
- 日本語
- Русский
- Português
- Italiano
- العربية
- हिन्दी
- Afrikaans
- Armenian
- Azerbaijani
- Bahasa Indonesia
- Bangla
- Basque
- Bulgarian
- Catalan
Show 45 more
- Croatian
- Czech
- Danish
- Egyptian Arabic
- Esperanto
- Estonian
- Faroese
- Finnish
- Galician
- Gothic
- Greek
- Hebrew
- Hungarian
- Icelandic
- Ido
- Irish
- Latin
- Latvian
- Lingua Franca Nova
- Lithuanian
- Malay
- Mongolian
- Nederlands
- Norwegian
- Norwegian Nynorsk
- Odia
- Polski
- Romanian
- Scots
- Serbian
- Serbian (Latin)
- simple
- Slovenian
- Svenska
- Swahili
- Tiếng Việt
- Türkçe
- Ukrainian
- Uzbek
- Welsh
- zh_min_nan
- zh_yue
- فارسی
- ไทย
- 한국어
via Wikidata sitelinks · CC0